HM Payson & Co’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,200
Closed -$25K 1019
2022
Q3
$25K Hold
1,200
﹤0.01% 667
2022
Q2
$25K Sell
1,200
-1,000
-45% -$17.8K ﹤0.01% 684
2022
Q1
$37K Sell
2,200
-2,225
-50% -$38.9K ﹤0.01% 644
2021
Q4
$88K Hold
4,425
﹤0.01% 521
2021
Q3
$80K Sell
4,425
-400
-8% -$9.17K ﹤0.01% 520
2021
Q2
$130K Sell
4,825
-615
-11% -$17.2K ﹤0.01% 441
2021
Q1
$163K Sell
5,440
-925
-15% -$31.5K ﹤0.01% 423
2020
Q4
$183K Sell
6,365
-80
-1% -$2.16K 0.01% 396
2020
Q3
$157K Sell
6,445
-6,994
-52% -$151K ﹤0.01% 394
2020
Q2
$240K Buy
13,439
+7,589
+130% +$99.7K 0.01% 313
2020
Q1
$48K Sell
5,850
-40
-0.7% -$457 ﹤0.01% 508
2019
Q4
$78K Sell
5,890
-3,888
-40% -$47.1K ﹤0.01% 512
2019
Q3
$116K Sell
9,778
-140,665
-94% -$2.6M ﹤0.01% 461
2019
Q2
$3.68M Sell
150,443
-192,812
-56% -$5.56M 0.13% 107
2019
Q1
$10.9M Buy
+343,255
New +$12.2M 0.42% 60

Other funds holding CVET

HM Payson & Co's CVET Position: Q4 2022 in Review

HM Payson & Co sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 1,200 shares — an estimated $25K sold.

HM Payson & Co first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $10.9M in Q1 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • HM Payson & Co reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • HM Payson & Co sold 1,200 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $25K.
  • HM Payson & Co first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • HM Payson & Co's Covetrus, Inc. Common Stock position peaked at $10.9M in Q1 2019.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on HM Payson & Co's 13F filing for Q4 2022, filed 6 Feb 2023.